1. Home
  2. ECOR vs BGSF Comparison

ECOR vs BGSF Comparison

Compare ECOR & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • BGSF
  • Stock Information
  • Founded
  • ECOR 2005
  • BGSF 2007
  • Country
  • ECOR United States
  • BGSF United States
  • Employees
  • ECOR N/A
  • BGSF N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BGSF Professional Services
  • Sector
  • ECOR Health Care
  • BGSF Consumer Discretionary
  • Exchange
  • ECOR Nasdaq
  • BGSF Nasdaq
  • Market Cap
  • ECOR 50.1M
  • BGSF 47.7M
  • IPO Year
  • ECOR 2018
  • BGSF N/A
  • Fundamental
  • Price
  • ECOR $6.11
  • BGSF $7.35
  • Analyst Decision
  • ECOR Strong Buy
  • BGSF Strong Buy
  • Analyst Count
  • ECOR 2
  • BGSF 1
  • Target Price
  • ECOR $25.50
  • BGSF $9.00
  • AVG Volume (30 Days)
  • ECOR 71.2K
  • BGSF 268.8K
  • Earning Date
  • ECOR 08-06-2025
  • BGSF 08-06-2025
  • Dividend Yield
  • ECOR N/A
  • BGSF N/A
  • EPS Growth
  • ECOR N/A
  • BGSF N/A
  • EPS
  • ECOR N/A
  • BGSF N/A
  • Revenue
  • ECOR $26,458,000.00
  • BGSF $266,968,000.00
  • Revenue This Year
  • ECOR $23.21
  • BGSF $0.59
  • Revenue Next Year
  • ECOR $44.10
  • BGSF N/A
  • P/E Ratio
  • ECOR N/A
  • BGSF N/A
  • Revenue Growth
  • ECOR 41.54
  • BGSF N/A
  • 52 Week Low
  • ECOR $4.47
  • BGSF $2.91
  • 52 Week High
  • ECOR $19.49
  • BGSF $9.08
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 62.63
  • BGSF 85.60
  • Support Level
  • ECOR $5.13
  • BGSF $5.28
  • Resistance Level
  • ECOR $5.69
  • BGSF $7.70
  • Average True Range (ATR)
  • ECOR 0.42
  • BGSF 0.53
  • MACD
  • ECOR 0.09
  • BGSF 0.22
  • Stochastic Oscillator
  • ECOR 91.27
  • BGSF 90.72

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

Share on Social Networks: